Table 5.
RSV (n = 362) |
HCoV (n = 35) |
RSV + HCoV (n = 9) |
|||||
---|---|---|---|---|---|---|---|
Median [IQR]/number (%) | Median [IQR]/number (%) | Median [IQR]/number (%) | PA | PB | PC | PD | |
Age (Months) | 14.0 [3.3–25.0] | 16.0 [8.0–40.0] | 7.0 [1.0–20.0] | 0.047 | 0.076 | 0.424 | 0.167 |
<2 months | 58 (16.0) | 2 (5.7) | 3 (33.3) | ||||
2–5 months | 56 (15.5) | 5 (14.3) | 2 (11.1) | ||||
6–11 months | 46 (12.7) | 5 (14.3) | 3 (22.2) | ||||
12–23 months | 105 (29.0) | 9 (25.7) | 2 (22.2) | ||||
>24 months | 98 (27.1) | 14 (40.0) | 1 (11.1) | ||||
Sex (male) | 188 (51.9) | 25 (71.4) | 6 (66.7) | 0.067 | |||
Period from onset to hospitalization (day) | 4 [2–5] | 2 [1–4.5] | 3 [2–3] | 0.003 | 0.004 | 0.540 | 1.0 |
Hospitalization period (day) | 5 [4–6] | 4 [3–5] | 5 [4–5] | 0.007 | 0.008 | 0.897 | 1.0 |
Fever | 308 (85.1) | 32 (91.4) | 8 (88.9) | 0.670 | |||
Rhinorrhea | 280 (77.3) | 18 (51.4) | 8 (88.9) | 0.002 | |||
Cough | 344 (95.0) | 32 (91.4) | 9 (100) | 0.510 | |||
Wheezing | 95 (26.2) | 11 (31.4) | 1 (11.1) | 0.462 | |||
WBC (/μL) | 9600 [7200–12850] | 11300 [7300–15300] | 8900 [7100–10300] | 0.207 | |||
CRP (mg/dL) | 1.0 [0.2–2.7] | 1.2 [0.6–2.8] | 0.2 [0.1–0.8] | 0.138 | |||
Admission of PICU |
2 (0.6) |
0 (0.0) |
0 (0.0) |
0.885 |
|||
Diagnosis | |||||||
Tympanitis | 2 (0.6) | 2 (5.7) | 0 (0.0) | 0.012 | |||
URI | 14 (3.9) | 13 (37.1) | 0 (0.0) | <0.001 | |||
Croup | 1 (0.3) | 6 (17.1) | 0 (0.0) | <0.001 | |||
LRI | 343 (94.8) | 19 (54.3) | 9 (100) | <0.001 |
PA: Kruskal–Wallis test or Chi-squared test, PB, PC, PD: Dunn's multiple comparison tests.
PB, RSV vs. HCoV; PC, RSV vs. RSV + HCoV PD, HCoV vs. RSV + HCoV.
Data are shown as median (IQR) or number (%).
IQR, interquartile range; WBC, white blood cell; CRP, C-reactive protein; PICU, pediatric intensive care unit; URI, upper respiratory infection; and LRI, lower respiratory infection.